Abstract
Purpose Interferon alpha, which is used to treat various systemic disorders, has many reversible side-effects involving various organ systems. In this study, chronic active hepatitis patients undergoing interferon alpha therapy were followed with regard to the ocular side-effects.
Methods Thirty-six patients with chronic active hepatitis undergoing subcutaneous interferon alpha therapy for 1 year were enrolled. Complete ocular examination and photographic documentation were performed at baseline of the therapy and monthly thereafter. Fisher's exact chi-squared test and Mann-Whitney U-test were employed in the statistical evaluation of the results.
Results Trichomegaly was noted in 2 (6%) patients. Fifteen patients (42%) were found to have retinopathy with cotton wool spot formation and splinter haemorrhages.
Conclusions These findings emphasise the need to monitor these retinal complications, which may result in loss of vision in patients receiving interferon alpha therapy.
Similar content being viewed by others
Article PDF
References
Baron S, Tyring SK, Fleischmann WR Jr, Coppenhaver DH, Niesel DW, Klimpel GR, et al. The interferons: mechanisms of action and clinical applications. JAMA 1991;226:1375–83.
Perrillo RP . Treatment of chronic hepatitis B with interferon: experience in western countries. Semin Liv Dis 1989;9:240–8.
Product information sheet. Kenilworth, NJ: Schering Corporation, 1988.
Jones GJ, Itri L . Safety and tolerance of recombinant interferon alpha-2a (Roferon-A) in cancer patients. Cancer 1986;57:1709–15.
Guyer DR, Tiedeman J, Yannuzzi LA, Slakter JS, Parke D, Kelley J, et al. Interferon-associated retinopathy. Arch Ophthalmol 1993;111:350–6.
Sugano S, Yanagimoto M, Suzuki T, Sato M, Onmura H, Aizawa H, Makino H . Retinal complications with elevated circulating plasma C5a associated with interferon-α therapy for chronic active hepatitis C. Am J Gastroenterol 1994;89:2054–6.
Soushi S, Kobayashi F, Obazawa H, Kigasawa K, Shiraishi K, Itakura M, et al. Evaluation of risk factors of interferon-associated retinopathy in patients with type C chronic active hepatitis. Nippon Ganka Gakkai Zasshi 1996;100:69–76.
Foon KA, Dougher G . Increased growth of eyelashes in a patient given leukocyte A interferon. N Engl J Med 1984;311:1259.
Jacobs AD, Levenson JE, Goldie DW . Induction of acute corneal allograft rejection by alpha-2 interferon. Am J Med 1987;82:181–2.
Chuman T, Nao-i N, Sawada A, Kawano T, Shigehira M . Interferon-induced retinal changes. Nippon Ganka Gakkai Zasshi 1994;98:616–21.
Hararda T, Fukami H, Takeuchi T, Niwa T, Majima Y . Interferone-assozierte Retinopathie. Klin Monatsbl Augenheilkd 1995;207:302–4.
Kawano T, Shigehira M, Uto H, Nakama T, Kato J, Hayashi K, et al. Retinal complications during interferon therapy for chronic hepatitis C. Am J Gastroenterol 1996;91:309–13.
Ab T, Nakajima A, Satoh N, Koizumi T, Sakuragi S, Ono T, et al. Clinical characteristics of hepatitis C virus-associated retinopathy. Jpn J Ophthalmol 1995;39:411–9.
Nishiwaki H, Ogura Y, Miyamoto K, Matsuda N, Honda Y . Interferon alpha induces leukocyte capillary trapping in rat retinal microcirculation. Arch Ophthalmol 1996;114:726–30.
Engler C, Sander B, Villumsen J, Lund Andersen H . Interferon alpha-2a modifies the course of subfoveal and juxtafoveal choroidal neovascularisation. Br J Ophthalmol 1994;78:749–53.
Chan CK, Kempin SJ, Noble SK, Palmer GA . The treatment of choroidal neovascular membranes by alpha interferon: an efficacy and toxicity study. Ophthalmology 1994;101:289–300.
Pharmacological Therapy for Macular Degeneration Study Group. Interferon alpha-2a is ineffective for patients with choroidal neovascularisation secondary to age related macular degeneration. Arch Ophthalmol 1997;115:865–72.
Çaliçkan S, Eldem B, Demirošlu H, Yaylali V, Ozcebe OI, Dündar S . Interferon alpha-2b in the treatment of Behçet's disease. Middle East J Ophthalmol 1995;3:94–9.
Nishiwaki H, Ogura Y, Miyamoto K, Hiroshiba N, Hamada M, Honda Y . Prednisolone, platelet-activating factor receptor antagonist, or Superoxide dismutase reduced leukocyte entrapment induced by interferon alpha in retinal microcirculation. Invest Ophthalmol Vis Sci 1997;38:811–6.
Author information
Authors and Affiliations
Additional information
Part of this work was presented at the XIth Congress of the European Society of Ophthalmology, 1997
Rights and permissions
About this article
Cite this article
Kadayifcilar, S., Boyacioglu, S., Kart, H. et al. Ocular complications with high-dose interferon alpha in chronic active hepatitis. Eye 13, 241–246 (1999). https://doi.org/10.1038/eye.1999.59
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/eye.1999.59
Keywords
This article is cited by
-
Rétinopathie à interferon pégylé alpha 2a et ribavirine au cours d’une hépatite virale C chronique
Journal Africain d'Hépato-Gastroentérologie (2013)
-
Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin
Japanese Journal of Ophthalmology (2009)
-
Typische Fragen aus der Rheumatologie an den Augenarzt und den kooperierenden Radiologen
Zeitschrift für Rheumatologie (2008)
-
Interferon-associated retinopathy
Eye (2003)
-
Presumed interferon-associated bilateral macular arterial branch obstruction
Eye (2000)